ArticleFrontiers in pharmacology2025

Efficacy and safety of intermittent intravenous doxercalciferol in the treatment of secondary hyperparathyroidism in Chinese patients on maintenance hemodialysis: a phase II, open-label, prospective, multicenter study.

Guang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.